Abstract:OBJECTIVETo investigate the expression of integrin beta3 and osteopontin (OPN) in eutopic and ectopic endometrium of adenomyosis.METHODSFrom January 2007 to July 2008, the endometrium specimens were collected from 43 patients with adenomyosis undergoing hysterectomy in Peking University First Hospital. Eutopic endometrium were 11 in proliferative phase and 32 in secretory phase (18 cases in mid-secretory phase) were collected. Ectopic endometriums were also collected. In the mean time, it was chosen 41 cases with pure subserous uterine myoma or cervical intraepithelial neoplasia (CIN) II-III treated by hysterectomy as controls including 12 endometrium in proliferative phase and 29 endometrium in secretory phase (19 cases in mid-secretory phase). The expression of Integrin beta3 subunit and OPN in the endometrium were assessed by immunohistochemical staining and quantitative real-time polymerase chain reaction.RESULTS(1) Immunohistochemical staining showed that positive staining of integrin beta3 and OPN were present predominantly in eutopic and ectopic endometrial glandular epithelium. There was significant different protein expression of integrin beta3 and OPN, which were 1.6 +/- 0.8 and 1.7 +/- 0.7 in eutopic endometrium, 1.7 +/- 0.7 and 1.8 +/- 0.9 in ectopic endometrium, 2.1 +/- 0.9 and 2.0 +/- 0.9 in control endometrium (P < 0.05). The protein expression of integrin beta3 and OPN in eutopic endometrium of adenomyosis in the proliferative phase (0.8 +/- 0.4 and 0.7 +/- 0.3) were remarkably lower than those of the secretory phase (1.8 +/- 0.8 and 1.9 +/- 0.8, P < 0.01). The protein expression of integrin beta3 and OPN in the endometrium of controls in the proliferative phase (1.0 +/- 0.4 and 1.0 +/- 0.4) were significantly lower than those of the secretory phase (2.5 +/- 0.7 and 2.5 +/- 0.7) (P = 0.000). In the mid-secretory phase, the protein expression of integrin beta3 (2.0 +/- 0.9) and OPN (2.1 +/- 0.8) in eutopic endometrium of adenomyosis were significantly lower than that of control endometrium (2.7 +/- 0.5 and 2.7 +/- 0.7) (P < 0.01). (2) The mRNA expression level of integrin beta and OPN in eutopic and ectopic endometrium were assessed by quantitative real-time PCR (result was shown by median index). It was observed that integrin beta3 mRNA and OPN mRNA were significantly lower in the eutopic endometrium of adenomyosis (4.69 and 4.23), when compared with ectopic endometrium (7.96 and 14.84) and controls (13.47 and 17.40) (P < 0.05). Eutopic endometrium had higher mRNA expression of integrin beta and OPN mRNA in the secretory phase (5.54 and 11.40) than that in the proliferative phase (2.69 and 3.30) (P < 0.01). The mRNA expression level of integrin beta and OPN of control endometrium in the proliferative phase (3.12 and 4.75) were significantly lower than that in the secretory phase (19.94 and 21.00, P = 0.000). The mRNA expression of integrin beta and OPN were 10.10 and 14.34 in the mid-secretory phase, which were significantly lower than 21.50 and 24.18 in control endometrium (P < 0.05).CONCLUSIONSHigh expression of integrin beta3 and OPN in ectopic endometrium of adenomyosis may cause endometriotic lesions; abnormal expression of integrin beta3 and OPN in the endometrium of adenomyosis during the implantation window may contribute to infertility in some patients.

Expression and significance of RhoE/Rnd3 protein in adenomyosis

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

The Possible Role of Eukaryotic Translation Initiation Factor 3 Subunit E (eif3e) in the Epithelial—Mesenchymal Transition in Adenomyosis

Expression of Cxcl12 and Its Receptor Cxcr4 in Patients with Adenomyosis

The Expression of Toll-like Receptors in Eutopic and Ectopic Endometrium and Its Implication in the Inflammatory Pathogenesis of Adenomyosis.

Expression and Significance of Chemokine CXCL12 in Uterine Adenomyosis

Expression of High-Mobility Group Box-1 in Eutopic/ectopic Endometrium and Correlations with Inflammation-Related Factors in Adenomyosis.

Abnormal Expression Of Nrf2 May Play An Important Role In The Pathogenesis And Development Of Adenomyosis

Expression and clinical significance of Akt and NF-κB in adenomyosis

The expression and methylation of PR-B in adenomyosis

Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis

Study on the Expression of Vascular Endothelial Growth Factor in Patients with Adenomyosis of the Uterus

Temporal and Spatial Expression of Estrogen Activity-Related Molecules in Eutopic Endometrium of Adenomyosis

[Expression of Integrin Beta3 and Osteopontin in Endometrium of Patients with Adenomyosis].

[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].

Prognostic Significance of Elongator Protein 3 Expression in Endometrioid Adenocarcinoma.

Expression and significance of LC3 and cathepsin D in human endometrioid adenocarcinoma.

Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis

Expressions of PTEN and Akt and Relationship to Adenomyosis

Transcriptome Sequencing of Adenomyosis Eutopic Endometrium: A New Insight into Its Pathophysiology.